Sainor Pharma Private Limited, a amalgamated private limited company, was established on 13 February 2004 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239TG2004PTC042653. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹3.54 Cr.
Its leadership includes Anjaneya Pattabhi Rameswara Rao Chandana (Director), Pullaiah Naidu Sundara (Director), Uddagiri Tata Rao (Managing Director). Past directors included Anjaneya Pattabhi Rameswara Rao Chandana, Aruna Kumari Chandana, Venkateswara Rao Talupula. It holds no open charges and ₹19.13 Cr settled loans. Its latest AGM occurred on 26 September 2016, with the balance sheet filed on 31 March 2016. It is based at Plot No. 31, Phase V Ida, Jeedimetla, Hyderabad, Telangana, 500055.
U24239TG2004PTC042653
042653
13 February 2004
₹4.00 Cr
₹3.54 Cr
Roc Hyderabad
Unlisted
Amalgamated
Explore comprehensive insights into Sainor Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anjaneya Pattabhi Rameswara Rao Chandana | Director | 06 Jun 2013 | Current |
| Pullaiah Naidu Sundara | Director | 13 Feb 2004 | Current |
| Uddagiri Tata Rao | Managing Director | 13 Feb 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 10 Jul 2013 | Past |
| Pramod Abcsdd | Director | 06 Jun 2013 | Past |
| Pramod Abcsdd | Director | 16 Jun 2016 | Past |
| Pramod Abcsdd | Director | 06 Jun 2011 | Past |
| Pramod Abcsdd | Director | 25 Sep 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sainor Pharma Private Limited, for the financial year ended 2016, experienced modest growth in revenue, with a 0.29% increase. The company also saw a substantial fall in profitability, with a 26.65% decrease in profit. The company's net worth moved up by a moderate rise of 3.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2016, Sainor Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹191,300,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Mar 2012 | State Bank Of India | ₹17.63 Cr | Satisfied |
| 26 Sep 2005 | Union Bank Of India | ₹1.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sainor Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sainor Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sainor Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sainor Pharma Private Limited last Annual general meeting of members was held on 26 Sep 2016 as per latest MCA records. was completed.
The activity Sainor Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Hyderabad. was completed.
The activity A charge registered on 05 Mar 2012 via Charge ID 10341792 with State Bank Of India was fully satisfied on 29 Feb 2016. was completed.
Anjaneya Pattabhi Rameswara Rao Chandana was appointed as a Director was appointed as a Director on 06 Jun 2013 & has been associated with this company since 12 years 5 months . was recorded as a recent event.
A charge with State Bank Of India of Rs. 17.63 Cr registered on 05 Mar 2012 with Charge ID 10341792 was modified on 31 Jan 2013. was recorded as a recent event.
Progress on A charge with State Bank Of India amounted to Rs. 17.63 Cr with Charge ID 10341792 was registered on 05 Mar 2012. was documented.
The CIN of Sainor Pharma Private Limited is U24239TG2004PTC042653.
Sainor Pharma Private Limited is headquartered at Plot No. 31, Phase V Ida, Jeedimetla, Hyderabad, Telangana, 500055.
Sainor Pharma Private Limited was incorporated on 13 February 2004.
The current directors of Sainor Pharma Private Limited are
The primary industry of Sainor Pharma Private Limited is Manufacturing.
Sainor Pharma Private Limited is unlisted.
The authorized capital of Sainor Pharma Private Limited is ₹4.00 Cr, and the paid-up capital is ₹3.54 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX